#ranibizumab

Live, measured metrics for the hashtag #ranibizumab from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.

hashtag.org network · sponsored

Own #ranibizumab

This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.

$10.85/ year · 11-character #name
Claim #ranibizumab — $10.85/yr→Buy on hashtag.space (web3)
card via hashtag.org · tokens via hashtag.space
0
Uses / 7 days
Mastodon
0
Accounts / 7 days
Mastodon
10
Recent posts
Mastodon
~0/hr
Recent pace
Mastodon · last 10
0
Avg reactions / post
Mastodon · last 10
—
Reddit posts / month
Reddit search
—
Open-web mentions
hashtag.org Firehose

Day-by-day usage

measured · mas.to (Mastodon public tags API) · fetched 2026-10-16 12:22 UTC
0
10-10
0
10-11
0
10-12
0
10-13
0
10-14
0
10-15
0
10-16

0 uses by 0 unique accounts across the window. Real per-day counts, not estimates. Newest bar is today so far.

Related hashtags

measured · mas.to (Mastodon public search API) · fetched 2026-10-16 12:22 UTC

No related tags with measured usage found for #ranibizumab.

Live pulse

measured · mas.to (Mastodon tag timeline) · fetched 2026-10-16 12:22 UTC

Everything below is measured over the latest 10 public posts (spanning ~28191 hours).

Posting hours (UTC)

00:0012:0023:00

Languages: English (10)

Avg boosts / post: 0.2

Top of the latest posts

  • European Commission approves Roche’s Susvimo® for the treatment of neovascular age-related macular degeneration (nAMD) F. Hoffmann-La Roche Ltd By continuously delivering medicine into the eye through the Contivue refillable implant, Susvim

    Europe@[email protected]♥ 0↻ 02026-09-21 18:00 UTCView post →

  • https://www.europesays.com/ch/134053/ European Commission approves Roche’s Susvimo® for the treatment of neovascular age-related macular degeneration (nAMD) #ContinuousDelivery #EuropeanCommission #EuropeanUnion #MacularDegeneration #Macula

    Switzerland@[email protected]♥ 0↻ 02026-09-21 16:28 UTCView post →

  • https://www.europesays.com/ch/127377/ Novartis enters into exclusive promotion and distribution agreement with Novartis Healthcare | Capital Market News #AntivascularEndothelialGrowthFactorTherapy #Biotechnology&MedicalResearch(NEC) #Breakt

    Switzerland@[email protected]♥ 0↻ 02026-09-08 05:38 UTCView post →

What “ranibizumab” means

Wikipedia

Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that is approved to treat the "wet" type of age-related macular degeneration, diabetic retinopathy, and macular edema due to branch retinal vein occlusion or central retinal vein occlusion.

“Ranibizumab” on Wikipedia (CC BY-SA) →

#ranibizumab across platforms

every network with a public tag surface

Follow #ranibizumab straight to each platform’s own tag page. Where a platform publishes open data we measure it above; the rest lock their numbers behind paid APIs, so we link rather than guess.

X (Twitter) ↗Instagram ↗TikTok ↗Facebook ↗LinkedIn ↗YouTube ↗Threads ↗Bluesky ↗Mastodon ↗Reddit ↗Pinterest ↗Tumblr ↗

Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/ranibizumab